Christopher Ignace is a pharmaceutical professional with over 13 years of experience in nuclear drugs and an extensive background in developing and securing approval for new and generic drug products spanning two decades. They have held leadership roles, including Senior Vice President at Nusano, where they focus on quality, scientific, and regulatory affairs, providing strategic input for compliant product development. Previously, Christopher served as Vice President at Cardinal Health, Zila Pharmaceuticals, and Abraxis BioScience, demonstrating expertise in clinical operations, regulatory compliance, and product development. They earned a Ph.D. in Pharmaceutics from the University of Iowa and an MBA in International Management from Western International University.
This person is not in any teams
This person is not in any offices